How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Bintrail is a recently introduced layer that brings point-in-time queries and row-history lookups to MySQL, the only major ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Storm-2949 turned stolen credentials into a cloud-wide breach, moving from identity compromise to large-scale data theft ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Across all regions, persons with disabilities and their households face challenges and barriers in the attainment of social development objectives: They are more likely to live in poverty; They ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...